NCT02892110View on ClinicalTrials.gov

Varenicline Treatment for Cannabis Use Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

February 13, 2017

Primary Completion Date

November 8, 2018

Study Completion Date

November 27, 2018

Conditions
Substance Use Disorder
Interventions
DRUG

Varenicline

2 mg daily

DRUG

Placebo

2 mg daily

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Medical University of South Carolina

OTHER

NCT02892110 - Varenicline Treatment for Cannabis Use Disorder | Biotech Hunter | Biotech Hunter